TerminatedPhase 3

Comparison of Two Pharmacological Treatments of Pedophilia

France48 participantsStarted 2007-12

Plain-language summary

Sexual abuse committed on children is a major public health problem because of its frequency and its severe consequences on the mental health of victims. Objective: to compare the therapeutic efficacy of cyproterone acetate (CPA) and leuprolide, with the hypothesis that leuprolide will be more effective.

Who can participate

Age range18 Years – 60 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * clinical diagnosis of pedophilia * high frequency of sexual urges and deviant behavior as demonstrated by a score equal to 8 on the scale of Rösler \& Witztum (Rösler \& Witztum, 1998) ; * age: 18-60 years * informed consent Exclusion Criteria: * IQ\<70 * schizophrenia, schizoaffective disorder, or delusional disorder * already receiving one of the tested drugs * contraindication for one of the tested drugs * no current or planned incarceration

What they're measuring

Questionnaire on sexual behavior

Timeframe: prospective

Trial details

NCT IDNCT00601276

SponsorInstitut National de la Santé Et de la Recherche Médicale, France

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2009-06

View on ClinicalTrials.gov More Pedophilia trials